These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 14521988
1. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. Lannuzel A, Michel PP, Höglinger GU, Champy P, Jousset A, Medja F, Lombès A, Darios F, Gleye C, Laurens A, Hocquemiller R, Hirsch EC, Ruberg M. Neuroscience; 2003; 121(2):287-96. PubMed ID: 14521988 [Abstract] [Full Text] [Related]
2. Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. Escobar-Khondiker M, Höllerhage M, Muriel MP, Champy P, Bach A, Depienne C, Respondek G, Yamada ES, Lannuzel A, Yagi T, Hirsch EC, Oertel WH, Jacob R, Michel PP, Ruberg M, Höglinger GU. J Neurosci; 2007 Jul 18; 27(29):7827-37. PubMed ID: 17634376 [Abstract] [Full Text] [Related]
3. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures. Michel PP, Agid Y. Brain Res; 1992 Dec 04; 597(2):233-40. PubMed ID: 1361874 [Abstract] [Full Text] [Related]
4. Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe. Champy P, Höglinger GU, Féger J, Gleye C, Hocquemiller R, Laurens A, Guérineau V, Laprévote O, Medja F, Lombès A, Michel PP, Lannuzel A, Hirsch EC, Ruberg M. J Neurochem; 2004 Jan 04; 88(1):63-9. PubMed ID: 14675150 [Abstract] [Full Text] [Related]
6. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF. Park TH, Mytilineou C. Brain Res; 1992 Dec 18; 599(1):83-97. PubMed ID: 1362921 [Abstract] [Full Text] [Related]
7. Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe. Lannuzel A, Michel PP, Caparros-Lefebvre D, Abaul J, Hocquemiller R, Ruberg M. Mov Disord; 2002 Jan 18; 17(1):84-90. PubMed ID: 11835443 [Abstract] [Full Text] [Related]
11. Is atypical parkinsonism in the Caribbean caused by the consumption of Annonacae? Lannuzel A, Höglinger GU, Champy P, Michel PP, Hirsch EC, Ruberg M. J Neural Transm Suppl; 2006 Jan 18; (70):153-7. PubMed ID: 17017523 [Abstract] [Full Text] [Related]
12. Relationship between NMDA receptor expression and MPP+ toxicity in cultured dopaminergic cells. Church WH, Hewett SJ. J Neurosci Res; 2003 Sep 15; 73(6):811-7. PubMed ID: 12949907 [Abstract] [Full Text] [Related]
13. Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices. Bywood PT, Johnson SM. Exp Neurol; 2003 Jan 15; 179(1):47-59. PubMed ID: 12504867 [Abstract] [Full Text] [Related]
17. Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins. Callizot N, Combes M, Henriques A, Poindron P. PLoS One; 2019 Jan 15; 14(4):e0215277. PubMed ID: 31022188 [Abstract] [Full Text] [Related]
18. Stage-dependent vulnerability of fetal mesencephalic neuroprogenitors towards dopaminergic neurotoxins. Sabolek M, Mieskes I, Lenk T, Lehmensiek V, Hermann A, Schwarz J, Storch A. Neurotoxicology; 2008 Jul 15; 29(4):714-21. PubMed ID: 18513801 [Abstract] [Full Text] [Related]